A detailed history of Kestra Advisory Services, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 16,275 shares of CVRX stock, worth $268,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,275
Previous 17,875 8.95%
Holding current value
$268,049
Previous $214,000 33.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.15 - $12.37 $11,440 - $19,792
-1,600 Reduced 8.95%
16,275 $143,000
Q2 2024

Aug 14, 2024

SELL
$6.49 - $19.2 $9,086 - $26,880
-1,400 Reduced 7.26%
17,875 $214,000
Q1 2024

May 15, 2024

BUY
$17.99 - $30.49 $87,251 - $147,876
4,850 Added 33.62%
19,275 $350,000
Q4 2023

Feb 14, 2024

SELL
$11.67 - $33.01 $187,303 - $529,810
-16,050 Reduced 52.67%
14,425 $453,000
Q3 2023

Nov 09, 2023

BUY
$13.56 - $18.47 $413,241 - $562,873
30,475 New
30,475 $462,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $339M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.